Posted on by ScienceFather
67 / 100
Powered by Rank Math SEO

Prof Shein-Chung Chow, clinical trials, Best Researcher Award.

Duke University School of Medicine, United States

👨‍🏫 Introduction:

Professor Shein-Chung Chow, Ph.D., a prominent figure in the field of biostatistics and bioinformatics. Currently holding the position of Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine in Durham, North Carolina, USA, Dr. Chow’s influence extends globally as an Adjunct Professor at esteemed institutions such as Peking University and Beijing Capital Medical University in Beijing, China.

 

Professional Profiles:

SCOPUS

🎓 Education Journey:

Embarking on an illustrious academic journey, Professor Shein-Chung Chow, Ph.D., earned his stripes in the realm of biostatistics. The foundation of his expertise was laid at institutions of high repute, culminating in a distinguished career. Dr. Chow’s academic prowess is exemplified by his significant contributions as a Professor at the Department of Biostatistics and Bioinformatics, Duke University School of Medicine in Durham, North Carolina, USA. His global impact extends further as an Adjunct Professor at Peking University and Beijing Capital Medical University in Beijing, China. Through his educational endeavors, Dr. Chow has not only enriched the academic landscape but has also become a pivotal figure in shaping the future of biostatistics, marked by a trailblazing career and unwavering commitment to advancing statistical methodologies. 🌐

🔬 FDA Journey:

Dr. Chow’s contributions to the field are not confined to academia. He served as a special government employee appointed by the United States Food and Drug Administration (FDA), wielding expertise as an Oncologic Drug Advisory Committee (ODAC) voting member and Statistical Advisor from 2015 to 2017 and then again from 2019 to 2022. During the period of 2017-2019, he took leave from the FDA to serve as an Associate Director at the Office of Biostatistics, Center for Drug Evaluation and Research (CDER), FDA.

📚 Editorial Leadership:

With an impressive editorial journey, Dr. Chow served as the Editor-in-Chief of the Journal of Biopharmaceutical Statistics for nearly three decades, from 1992 to 2020. Currently, he continues to shape the biostatistics landscape as the Editor-in-Chief of the Biostatistics Book Series at Chapman and Hall/CRC Press of Taylor & Francis Group.

🏆 Accolades:

His stellar career has earned him recognition, becoming a Fellow of the American Statistical Association in 1995 and an elected member of the ISI (International Statistical Institute) in 1999.

📚 Top Noted  Publications by Prof. Shein-Chung Chow:

Design and Analysis of Bioavailability and Bioequivalence Studies

 

Design and Analysis of Clinical Trials

 

Analytical Similarity Assessment in Biosimilar Drug Development

 

Advanced Statistics in Regulatory Critical Clinical Initiatives

 

Innovative Methods for Rare Disease Drug Development

 

In conclusion, Professor Shein-Chung Chow’s multifaceted career seamlessly blends academia, regulatory service, editorial leadership, and prolific authorship. His enduring impact on biostatistics and drug development is not only felt within the academic corridors but also within the regulatory framework, shaping the industry’s statistical landscape. Dr. Chow’s journey stands as a testament to his unwavering commitment to advancing statistical methodologies and fostering innovation in the realm of rare disease drug development.

Prof Shein-Chung Chow | clinical trials | Best Researcher Award |

You May Also Like